Performance-based exposure control limits for pharmaceutical active ingredients

American Industrial Hygiene Association Journal
B D NaumannG D Kirk

Abstract

For many years pharmaceutical companies have established employee exposure limits for the active ingredients used in their products. Historically these limits were derived using traditional risk assessment methods. Because the trend in the pharmaceutical industry is to identify and develop more selective drugs of increasing potency, and because of the difficulty in identifying no-effect levels for certain drugs, a new performance-based approach for setting limits was developed. This method involves assigning materials into one of five hazard categories according to their inherent toxicological and pharmacological properties. The criteria used to assign compounds into performance-based exposure control limit (PB-ECL) categories focus on the degree to which exposure impacts human health. These assignments dictate the level of containment required to assure employee safety that is achieved through the use of engineering controls and safe handling practices. Several matrices were developed to specify general design concepts and controls for unit operations in laboratory and manufacturing operations. Containment options range from conventional handling practices for low potency (PB-ECL Category 1) materials, to technologically advan...Continue Reading

Citations

Apr 15, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Nadine F J Van NimmenHendrik A F Veulemans
Aug 8, 2009·Nature Nanotechnology·Vladimir Murashov, John Howard
Apr 26, 2007·Journal of Exposure Science & Environmental Epidemiology·Chris D MoneyGauke Veenstra
Jul 22, 2006·Journal of Occupational and Environmental Hygiene·Howard Cohen, Eugene M White
Mar 20, 2008·Journal of Occupational and Environmental Hygiene·David M Zalk, Deborah Imel Nelson
Dec 14, 2011·Journal of Occupational and Environmental Hygiene·Vladimir MurashovJohn Howard
Jun 8, 2006·The Annals of Occupational Hygiene·N F J Van NimmenH A F Veulemans
Jul 16, 2008·The Annals of Occupational Hygiene·Erik TielemansWouter Fransman
Nov 5, 2010·The Annals of Occupational Hygiene·Eun Gyung LeeMartin Harper
Nov 11, 2006·Annual Review of Public Health·Kathleen KreissChristine R Schuler
Feb 1, 2014·Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology·P A SchulteK F Martinez
May 29, 2010·Toxicology Mechanisms and Methods·Dean M CalhounJoe L Nieusma
Oct 28, 1999·Drug and Chemical Toxicology·E V SargentB D Naumann
Feb 15, 2003·Journal of Pharmaceutical Sciences·Michael B HicksJoseph E Lynch
Feb 7, 2012·Regulatory Toxicology and Pharmacology : RTP·Ester Lovšin BarleRudolf Bechter
Jan 1, 2016·The Annals of Occupational Hygiene·Erwan ChenevalJoseph Zayed
Nov 9, 2007·Journal of Biochemical and Biophysical Methods·A OsytekM Szewczyńska
Oct 11, 2015·Regulatory Toxicology and Pharmacology : RTP·Selene ArayaSusanne Glowienke
Nov 20, 2015·Journal of Occupational and Environmental Hygiene·G S DotsonI Kimber
Aug 16, 2005·Regulatory Toxicology and Pharmacology : RTP·David G DolanMichael Dourson
May 8, 2015·Journal of Occupational and Environmental Hygiene·Vladimir Murashov, John Howard
May 16, 2014·Journal of Occupational and Environmental Hygiene·Kenneth W FentCharles Mueller
Dec 29, 2013·Journal of Occupational and Environmental Hygiene·C Champmartin, F Clerc
May 22, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ester Lovsin BarleHans-Joerg Martus
May 29, 2016·Regulatory Toxicology and Pharmacology : RTP·Ellen C FariaPatricia A Weideman
Jun 9, 2016·Regulatory Toxicology and Pharmacology : RTP·Robert G SussmanPatricia A Weideman
Jul 30, 2016·Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology·Adrienne EastlakeCharles Geraci
Dec 7, 2007·Regulatory Toxicology and Pharmacology : RTP·K N Woodward
Feb 9, 2008·Journal of Occupational and Environmental Hygiene·Paul SchulteEileen Kuempel
Mar 13, 2018·Annals of Work Exposures and Health·Kevin H DunnEileen D Kuempel
Feb 11, 1999·Risk Analysis : an Official Publication of the Society for Risk Analysis·R I NiemeläM K Kiilunen
Jan 6, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Vladimir Murashov
Mar 14, 2009·Journal of Occupational and Environmental Hygiene·Anne L BrackerNancy J Simcox
Jul 6, 2018·Frontiers in Chemistry·Roberta Risoluti, Stefano Materazzi
Mar 5, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Thomas H ConnorRobert Dechristoforo
Jan 1, 2013·Journal of Physics. Conference Series·P A SchulteD S Heidel
Sep 1, 2012·Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology·E D KuempelP A Schulte
Sep 25, 2019·Toxicology and Industrial Health·Bruce D Naumann, Susan F Arnold
Jan 26, 2011·Journal of Environmental Monitoring : JEM·Patricia E McDonnellMarie A Coggins
Jan 8, 2013·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Gurumurthy RamachandranMartin Philbert
Jun 8, 2021·Journal of Pharmaceutical Sciences·Saikishore MeruvaSumit Kumar
Jul 14, 2021·Journal of Applied Toxicology : JAT·Varun Ahuja, Mohan Krishnappa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.